サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1713171

薬剤耐性（AMR）診断の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Antimicrobial Resistance Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 160 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
薬剤耐性（AMR）診断の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月23日
発行: Persistence Market Research
ページ情報: 英文 160 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の薬剤耐性（AMR）診断の市場規模は、2025年に48億3,070万米ドルになるとみられ、2025年～2032年の予測期間に6.7%のCAGRで拡大し、2032年には76億2,010万米ドルに達すると予測されています。

薬剤耐性（AMR）診断は、微生物病原体の抗生物質耐性を検出し、対処する上で重要な役割を果たしています。これらの診断は、耐性感染症の正確な同定と治療に不可欠であり、抗生物質の誤用を防ぎ、効果的な治療レジメンを推進する上で極めて重要です。AMR診断市場は、病院、診断センター、診療所にサービスを提供し、分子診断、培養法、迅速診断検査など、さまざまな診断ツールを提供しています。市場成長の原動力は、薬剤耐性感染症の増加、AMRに対する意識の高まり、治療成績向上のための個別化医療のニーズの高まりです。

世界のAMR診断市場は、世界の薬剤耐性感染症の蔓延の拡大など、いくつかの重要な要因によって牽引されています。耐性病原体が出現し続ける中、ヘルスケアプロバイダーは感染症を効果的に治療する上で大きな課題に直面しており、これが正確で迅速な診断に対する需要を促進しています。さらに、研究開発への投資の増加や、次世代シーケンシングやマルチプレックスPCR検査などの先進診断ツールの開発が、市場の拡大を後押ししています。AMR啓発プログラムに対する政府やヘルスケア機関の支援の高まりや、AMR診断ソリューションの臨床への統合は、さらに市場拡大に寄与しています。さらに、抗菌薬スチュワードシップ・プログラムや感染制御対策の改善が重視されるようになり、AMR診断の採用が加速すると予想されます。

有望な成長が見込まれますが、AMR診断市場は、特に新興国において、特定の診断検査に対する高コストと償還制限に関連する課題に直面しています。また、新しい診断技術の承認プロセスや国際基準への準拠など、規制上のハードルも市場参入を遅らせる要因となっています。さらに、多様な患者集団における病原体の耐性株を正確に同定する診断ツールの開発は複雑であるため、技術的な課題もあります。これらの要因は、特にヘルスケア・インフラが限られている地域において、AMR診断の普及を阻む障壁となっています。

AMR診断市場は、分子診断学、AIを活用した診断ツール、リアルタイムデータ解析の進歩により、大きな成長機会をもたらしています。診断プラットフォームに人工知能や機械学習を組み込むことで、耐性病原体をより迅速かつ正確に検出できるようになり、市場拡大の新たな道が開ける。さらに、個別化医療とプレシジョン・ヘルスケアへの注目の高まりは、治療成果を改善するためのオーダーメイド診断ソリューションの機会を提供します。診断企業、ヘルスケアプロバイダー、政府機関のパートナーシップは、アクセスの障壁を克服し、世界のヘルスケア環境でAMR診断ツールの利用可能性を拡大するのに役立つとみられています。

当レポートでは、世界の薬剤耐性（AMR）診断市場について調査し、製品タイプ別、技術別、病原体タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値のある洞察

第4章 世界の薬剤耐性診断市場の見通し

  • 主なハイライト
  • 市場規模（100万米ドル）分析と予測
    • 過去の市場規模（100万米ドル）分析、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、2025年～2032年
  • 世界の薬剤耐性診断市場の見通し：製品タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、製品タイプ別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、製品タイプ別、2025年～2032年
      • 機器
      • 試薬と消耗品
    • 市場の魅力分析：製品タイプ別
  • 世界の薬剤耐性診断市場の見通し：技術別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、技術別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、技術別、2025年～2032年
      • ポリメラーゼ連鎖反応（PCR）
      • 微生物学培養
      • 免疫測定
      • 次世代シーケンシング（NGS）
      • 質量分析
      • ポイントオブケア
      • その他
    • 市場の魅力分析：技術別
  • 世界の薬剤耐性診断市場の見通し：病原体タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、病原体タイプ別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、病原体タイプ別、2025年～2032年
      • メチシリン耐性黄色ブドウ球菌（MRSA）
      • 薬剤耐性肺炎球菌（DRSP）
      • 薬剤耐性カンピロバクター（DRC）
      • クロストリジウム・ディフィシル（CD）
      • 薬剤耐性淋菌（DRNG）
      • その他
    • 市場の魅力分析：病原体タイプ別
  • 世界の薬剤耐性診断市場の見通し：エンドユーザー別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、エンドユーザー別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、エンドユーザー別、2025年～2032年
      • 病院と診療所
      • 診断研究所
      • 研究機関
      • 製薬・バイオテクノロジー企業
      • その他
    • 市場の魅力分析：エンドユーザー別

第5章 世界の薬剤耐性診断市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模（100万米ドル）分析、地域別、2019年～2024年
  • 現在の市場規模（100万米ドル）分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第6章 北米の薬剤耐性診断市場の見通し

第7章 欧州の薬剤耐性診断市場の見通し

第8章 東アジアの薬剤耐性診断市場の見通し

第9章 南アジアおよびオセアニアの薬剤耐性診断市場の見通し

第10章 ラテンアメリカの薬剤耐性診断市場の見通し

第11章 中東・アフリカの薬剤耐性診断市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • bioMerieux
    • Roche Diagnostics
    • Cepheid
    • Hologic, Inc.
    • Thermo Fisher Scientific
    • Illumina, Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences（PacBio）
    • Qiagen
    • Agilent Technologies
    • Randox Laboratories
    • Bruker Corporation
    • Becton, Dickinson and Company（BD）
    • その他

第13章 付録

目次
Product Code: PMRREP35211

Persistence Market Research has recently released a comprehensive report on the worldwide market for antimicrobial resistance (AMR) diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global AMR diagnostics market from 2025 to 2032.

Key Insights:

  • AMR Diagnostics Market Size (2025E): USD 4,830.7 Million
  • Projected Market Value (2032F): USD 7,620.1 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.7%

AMR Diagnostics Market - Report Scope:

Antimicrobial resistance (AMR) diagnostics play a crucial role in detecting and addressing antibiotic resistance in microbial pathogens. These diagnostics are vital for accurate identification and treatment of resistant infections, which is critical in preventing the misuse of antibiotics and promoting effective treatment regimens. The AMR diagnostics market serves hospitals, diagnostic centers, and clinics, offering a range of diagnostic tools including molecular diagnostics, culture-based methods, and rapid diagnostic tests. Market growth is driven by the increasing prevalence of drug-resistant infections, rising awareness of AMR, and the growing need for personalized medicine to improve treatment outcomes.

Market Growth Drivers:

The global AMR diagnostics market is driven by several key factors, including the escalating prevalence of antimicrobial-resistant infections worldwide. As resistant pathogens continue to emerge, healthcare providers face significant challenges in treating infections effectively, which propels the demand for accurate and rapid diagnostics. Additionally, the increasing investment in R&D and the development of advanced diagnostic tools, such as next-generation sequencing and multiplex PCR tests, is boosting market expansion. The rising government and healthcare agency support for AMR awareness programs and the integration of AMR diagnostic solutions into clinical practice further contribute to market growth. Furthermore, the growing emphasis on antimicrobial stewardship programs and improved infection control measures is expected to accelerate the adoption of AMR diagnostics.

Market Restraints:

Despite promising growth prospects, the AMR diagnostics market faces challenges related to high costs and limited reimbursement for certain diagnostic tests, particularly in emerging economies. Regulatory hurdles, such as lengthy approval processes for new diagnostic technologies and compliance with international standards, can also slow market entry. Moreover, the complexity of developing diagnostic tools that accurately identify resistant strains of pathogens across diverse patient populations presents technical challenges. These factors create barriers to the widespread adoption of AMR diagnostics, particularly in regions with limited healthcare infrastructure.

Market Opportunities:

The AMR diagnostics market presents significant growth opportunities driven by advancements in molecular diagnostics, AI-powered diagnostic tools, and real-time data analysis. The integration of artificial intelligence and machine learning into diagnostic platforms enables faster and more accurate detection of resistant pathogens, creating new avenues for market expansion. Additionally, the increasing focus on personalized medicine and precision healthcare provides opportunities for tailored diagnostic solutions to improve treatment outcomes. Partnerships between diagnostic companies, healthcare providers, and government agencies will help overcome barriers to access and expand the availability of AMR diagnostic tools across global healthcare settings.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the AMR diagnostics market globally?
  • Which diagnostic methods and technologies are most widely adopted across healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the AMR diagnostics market?
  • Who are the key players contributing to the AMR diagnostics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global AMR diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the global AMR diagnostics market, including Roche Diagnostics, Abbott Laboratories, BioMerieux, and Cepheid, focus on innovation, product differentiation, and strategic partnerships to maintain their competitive edge. These companies invest in R&D to develop advanced diagnostic technologies such as next-generation sequencing, CRISPR-based diagnostics, and multiplex PCR tests. Collaborations with healthcare providers, academic institutions, and regulatory agencies are essential for accelerating the adoption of AMR diagnostics and ensuring compliance with evolving global standards. Additionally, increased focus on patient education and AMR awareness initiatives supports the market growth and enhances the effectiveness of diagnostic tools in combating antimicrobial resistance.

Key Companies Profiled:

  • Abbott Laboratories
  • Accelerated Diagnostics, USA
  • Alifax
  • Bio-Rad Laboratories
  • BioMerieux
  • Beckman Coulter
  • Becton, Dickinson and Company
  • F.Hoffmann-La Roche
  • Molsid
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Others

AMR Diagnostics Market Research Segmentation:

The AMR diagnostics market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various clinical needs and patient populations.

By Product Type

  • Instruments
  • Reagents & Consumables

By Technology

  • Polymerase Chain Reaction (PCR)
  • Microbiology Culture
  • Immunoassay
  • Next-generation sequencing (NGS)
  • Mass Spectrometry
  • Point-of-care
  • Others

By Pathogen Type

  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Drug-resistant Streptococcus pneumoniae (DRSP)
  • Drug-resistant Campylobacter (DRC)
  • Clostridium difficile (CD)
  • Drug-resistant Neisseria gonorrhoeae (DRNG)
  • Others

By End-user

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Antimicrobial Resistance Diagnostics Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Type Adoption Analysis
  • 3.3. Technological Advancements
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Antimicrobial Resistance Diagnostics Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Antimicrobial Resistance Diagnostics Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Instruments
      • 4.3.3.2. Reagents & Consumables
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Antimicrobial Resistance Diagnostics Market Outlook: Technology
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
      • 4.4.3.1. Polymerase Chain Reaction (PCR)
      • 4.4.3.2. Microbiology Culture
      • 4.4.3.3. Immunoassay
      • 4.4.3.4. Next-Generation Sequencing (NGS)
      • 4.4.3.5. Mass Spectrometry
      • 4.4.3.6. Point-of-care
      • 4.4.3.7. Others
    • 4.4.4. Market Attractiveness Analysis: Technology
  • 4.5. Global Antimicrobial Resistance Diagnostics Market Outlook: Pathogen Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Pathogen Type, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
      • 4.5.3.1. Methicillin-resistant Staphylococcus aureus (MRSA)
      • 4.5.3.2. Drug-resistant Streptococcus pneumoniae (DRSP)
      • 4.5.3.3. Drug-resistant Campylobacter (DRC)
      • 4.5.3.4. Clostridium difficile (CD)
      • 4.5.3.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
      • 4.5.3.6. Others
    • 4.5.4. Market Attractiveness Analysis: Pathogen Type
  • 4.6. Global Antimicrobial Resistance Diagnostics Market Outlook: End-user
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      • 4.6.3.1. Hospitals & Clinics
      • 4.6.3.2. Diagnostics Laboratories
      • 4.6.3.3. Research Institutes
      • 4.6.3.4. Pharmaceutical & Biotechnology Companies
      • 4.6.3.5. Others
    • 4.6.4. Market Attractiveness Analysis: End-user

5. Global Antimicrobial Resistance Diagnostics Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Antimicrobial Resistance Diagnostics Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Technology
    • 6.2.4. By Pathogen Type
    • 6.2.5. By End-user
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Instruments
    • 6.4.2. Reagents & Consumables
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 6.5.1. Polymerase Chain Reaction (PCR)
    • 6.5.2. Microbiology Culture
    • 6.5.3. Immunoassay
    • 6.5.4. Next-Generation Sequencing (NGS)
    • 6.5.5. Mass Spectrometry
    • 6.5.6. Point-of-care
    • 6.5.7. Others
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 6.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 6.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 6.6.3. Drug-resistant Campylobacter (DRC)
    • 6.6.4. Clostridium difficile (CD)
    • 6.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 6.6.6. Others
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 6.7.1. Hospitals & Clinics
    • 6.7.2. Diagnostics Laboratories
    • 6.7.3. Research Institutes
    • 6.7.4. Pharmaceutical & Biotechnology Companies
    • 6.7.5. Others
  • 6.8. Market Attractiveness Analysis

7. Europe Antimicrobial Resistance Diagnostics Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Technology
    • 7.2.4. By Pathogen Type
    • 7.2.5. By End-user
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Instruments
    • 7.4.2. Reagents & Consumables
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 7.5.1. Polymerase Chain Reaction (PCR)
    • 7.5.2. Microbiology Culture
    • 7.5.3. Immunoassay
    • 7.5.4. Next-Generation Sequencing (NGS)
    • 7.5.5. Mass Spectrometry
    • 7.5.6. Point-of-care
    • 7.5.7. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 7.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 7.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 7.6.3. Drug-resistant Campylobacter (DRC)
    • 7.6.4. Clostridium difficile (CD)
    • 7.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 7.6.6. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 7.7.1. Hospitals & Clinics
    • 7.7.2. Diagnostics Laboratories
    • 7.7.3. Research Institutes
    • 7.7.4. Pharmaceutical & Biotechnology Companies
    • 7.7.5. Others
  • 7.8. Market Attractiveness Analysis

8. East Asia Antimicrobial Resistance Diagnostics Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Technology
    • 8.2.4. By Pathogen Type
    • 8.2.5. By End-user
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Instruments
    • 8.4.2. Reagents & Consumables
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 8.5.1. Polymerase Chain Reaction (PCR)
    • 8.5.2. Microbiology Culture
    • 8.5.3. Immunoassay
    • 8.5.4. Next-Generation Sequencing (NGS)
    • 8.5.5. Mass Spectrometry
    • 8.5.6. Point-of-care
    • 8.5.7. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 8.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 8.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 8.6.3. Drug-resistant Campylobacter (DRC)
    • 8.6.4. Clostridium difficile (CD)
    • 8.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 8.6.6. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 8.7.1. Hospitals & Clinics
    • 8.7.2. Diagnostics Laboratories
    • 8.7.3. Research Institutes
    • 8.7.4. Pharmaceutical & Biotechnology Companies
    • 8.7.5. Others
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Antimicrobial Resistance Diagnostics Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Technology
    • 9.2.4. By Pathogen Type
    • 9.2.5. By End-user
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Instruments
    • 9.4.2. Reagents & Consumables
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 9.5.1. Polymerase Chain Reaction (PCR)
    • 9.5.2. Microbiology Culture
    • 9.5.3. Immunoassay
    • 9.5.4. Next-Generation Sequencing (NGS)
    • 9.5.5. Mass Spectrometry
    • 9.5.6. Point-of-care
    • 9.5.7. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 9.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 9.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 9.6.3. Drug-resistant Campylobacter (DRC)
    • 9.6.4. Clostridium difficile (CD)
    • 9.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 9.6.6. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 9.7.1. Hospitals & Clinics
    • 9.7.2. Diagnostics Laboratories
    • 9.7.3. Research Institutes
    • 9.7.4. Pharmaceutical & Biotechnology Companies
    • 9.7.5. Others
  • 9.8. Market Attractiveness Analysis

10. Latin America Antimicrobial Resistance Diagnostics Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Technology
    • 10.2.4. By Pathogen Type
    • 10.2.5. By End-user
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Instruments
    • 10.4.2. Reagents & Consumables
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 10.5.1. Polymerase Chain Reaction (PCR)
    • 10.5.2. Microbiology Culture
    • 10.5.3. Immunoassay
    • 10.5.4. Next-Generation Sequencing (NGS)
    • 10.5.5. Mass Spectrometry
    • 10.5.6. Point-of-care
    • 10.5.7. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 10.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 10.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 10.6.3. Drug-resistant Campylobacter (DRC)
    • 10.6.4. Clostridium difficile (CD)
    • 10.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 10.6.6. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 10.7.1. Hospitals & Clinics
    • 10.7.2. Diagnostics Laboratories
    • 10.7.3. Research Institutes
    • 10.7.4. Pharmaceutical & Biotechnology Companies
    • 10.7.5. Others
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Antimicrobial Resistance Diagnostics Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Technology
    • 11.2.4. By Pathogen Type
    • 11.2.5. By End-user
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Instruments
    • 11.4.2. Reagents & Consumables
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 11.5.1. Polymerase Chain Reaction (PCR)
    • 11.5.2. Microbiology Culture
    • 11.5.3. Immunoassay
    • 11.5.4. Next-Generation Sequencing (NGS)
    • 11.5.5. Mass Spectrometry
    • 11.5.6. Point-of-care
    • 11.5.7. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen Type, 2025-2032
    • 11.6.1. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 11.6.2. Drug-resistant Streptococcus pneumoniae (DRSP)
    • 11.6.3. Drug-resistant Campylobacter (DRC)
    • 11.6.4. Clostridium difficile (CD)
    • 11.6.5. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 11.6.6. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 11.7.1. Hospitals & Clinics
    • 11.7.2. Diagnostics Laboratories
    • 11.7.3. Research Institutes
    • 11.7.4. Pharmaceutical & Biotechnology Companies
    • 11.7.5. Others
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. bioMerieux
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Roche Diagnostics
    • 12.3.3. Cepheid
    • 12.3.4. Hologic, Inc.
    • 12.3.5. Thermo Fisher Scientific
    • 12.3.6. Illumina, Inc.
    • 12.3.7. Oxford Nanopore Technologies
    • 12.3.8. Pacific Biosciences (PacBio)
    • 12.3.9. Qiagen
    • 12.3.10. Agilent Technologies
    • 12.3.11. Randox Laboratories
    • 12.3.12. Bruker Corporation
    • 12.3.13. Becton, Dickinson and Company (BD)
    • 12.3.14. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations